BARCLAYS PLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 90 filers reported holding GW PHARMACEUTICALS PLC in Q3 2014. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$4,235,000
-48.5%
19,524
-72.6%
0.00%
-50.0%
Q4 2020$8,231,000
-8.1%
71,327
-22.5%
0.00%
-20.0%
Q3 2020$8,958,000
+27.4%
92,020
+60.6%
0.01%
-16.7%
Q2 2020$7,030,000
+17.6%
57,282
-16.1%
0.01%
+20.0%
Q1 2020$5,977,000
-37.8%
68,252
-25.7%
0.01%0.0%
Q4 2019$9,604,000
-26.3%
91,849
-19.0%
0.01%
-37.5%
Q3 2019$13,039,000
-23.2%
113,344
+15.1%
0.01%
-20.0%
Q2 2019$16,971,000
-67.1%
98,452
-67.8%
0.01%
-72.2%
Q1 2019$51,568,000
-28.5%
305,908
-58.7%
0.04%
-35.7%
Q4 2018$72,104,000
+31.6%
740,355
+133.5%
0.06%
+51.4%
Q3 2018$54,781,000
-16.6%
317,135
-32.6%
0.04%
-33.9%
Q2 2018$65,649,000
+203.9%
470,469
+145.4%
0.06%
+229.4%
Q1 2018$21,602,000
+1388.8%
191,714
+1642.9%
0.02%
+1600.0%
Q4 2017$1,451,000
-18.3%
11,000
-37.1%
0.00%
-50.0%
Q3 2017$1,776,000
-61.2%
17,500
-61.7%
0.00%
-60.0%
Q2 2017$4,580,000
-49.8%
45,700
-39.4%
0.01%
-50.0%
Q1 2017$9,118,000
-64.6%
75,400
-67.2%
0.01%
-64.3%
Q4 2016$25,727,000
-43.5%
230,217
-32.8%
0.03%
-44.0%
Q3 2016$45,500,000
+689.9%
342,800
+328.5%
0.05%
+455.6%
Q1 2016$5,760,000
-83.0%
80,000
-83.7%
0.01%
-78.0%
Q4 2015$33,861,000
+1841.6%
490,752
+2461.2%
0.04%
+1950.0%
Q3 2015$1,744,000
+19277.8%
19,161
+18324.0%
0.00%
Q1 2015$9,0000.0%104
-11.9%
0.00%
Q3 2014$9,000
+800.0%
118
+594.1%
0.00%
Q1 2014$1,000
-99.9%
17
-99.9%
0.00%
-100.0%
Q4 2013$1,185,00028,9000.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q3 2014
NameSharesValueWeighting ↓
VHCP Management, LLC 311,853$25,213,00011.33%
Iguana Healthcare Management, LLC 50,000$4,043,0002.16%
Ghost Tree Capital, LLC 35,000$2,830,0001.54%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 354,278$28,643,0001.06%
Cupps Capital Management, LLC 100,213$8,102,0000.75%
CLOUGH CAPITAL PARTNERS L P 192,600$15,572,0000.58%
FARALLON CAPITAL MANAGEMENT LLC 244,000$19,727,0000.32%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 105,200$8,505,0000.31%
Eventide Asset Management 25,000$2,021,0000.28%
PRUDENTIAL PLC 836,124$67,601,0000.28%
View complete list of GW PHARMACEUTICALS PLC shareholders